The National Consortium of Pulmonary Embolism Response Teams: Developing effective solutions to a devastating illness

The PERT consortium brings together clinicians who focus on pulmonary embolism to better the treatment of these patients

Latest from Twitter

3rd Annual Pulmonary Embolism Symposium

A National Continuing Professional Education Event

June 23-24, 2017

The Royal Sonesta Boston

PULMONARY EMBOLISM

What is Known, and What We Need to Know
State of the Art and Scientific Update

Registration Now Open

PULMONARY EMBOLISM

A State of the Art, and Scientific Update

Pulmonary embolism (PE) is a life-threatening condition that affects people of all ages and health statuses, from the most fit athletes to the most infirm patients. Detection of PE, “the great masquerader,” is challenging because its signs and symptoms are often subtle and mimic those of other disease states. Once PE is diagnosed, clinicians have little guidance in choosing from the wide array of therapies available because:

  • No accepted algorithm exists to guide diagnostic and therapeutic decision making
  • Outcomes data and evaluation for available therapies are lacking
  • Care rendered to PE patients is fragmented among different clinical services
  • Assessment of bleeding and other risks remains daunting
  • Long-term effects of PE are poorly understood, though they can be severely debilitating

In the face of these challenges, multidisciplinary rapid-response programs promoting coordination among specialists who care for PE patients, such as the Pulmonary Embolism Response Team (PERT) initiative at Massachusetts General Hospital, are gaining traction. These initiatives hold the promise to:

  • Improve interdisciplinary communication and collaboration
  • Facilitate timely decision-making to enhance care
  • Enable systematic collection and evaluation of data related to PE treatment and outcomes

The purposes of this symposium are to improve PE diagnosis, care coordination, and treatment, while expanding our knowledge of the underlying mechanisms and long-term follow-up strategies for patients with PE.